EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MiR133b ‐mediated inhibition of EGFR‐PTK pathway promotes rAAV2 transduction by facilitating intracellular trafficking and augmenting second‐strand synthesis

Xiaoping Huang iD, Xiao Wang, Ling Li, Qizhao Wang, Wentao Xu, Wenlin Wu, Xiaolan Xie, Yong Diao

Journal of Cellular and Molecular Medicine · 2023

DOI: 10.1111/jcmm.17858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Xiaoping Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical Engineering and Materials Sciences, Quanzhou Normal University, Quanzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant adeno‐associated virus (rAAV) is an extremely attractive vector in the in vivo delivery of gene therapy as it is safe and its genome is simple. However, challenges including low permissiveness to specific cells and restricted tissue specificity have hindered its clinical application. Based on the previous studies, epidermal growth factor receptor‐protein tyrosine kinase (EGFR‐PTK) negatively regulated rAAV transduction, and EGFR‐positive cells were hardly permissive to rAAV transduction. We constructed a novel rAAV‐miRNA133b vector, which co‐expressed miRNA133b and transgene, and investigated its in vivo and in vitro transduction efficiency. Confocal microscopy, live‐cell imaging, pharmacological reagents and labelled virion tracking were used to analyse the effect of miRNA133b on rAAV2 transduction and the underlying mechanisms. The results demonstrated that miRNA133b could promote rAAV2 transduction and the effects were limited to EGFR‐positive cells. The increased transduction was found to be a direct result of decreased rAAV particles degradation in the cytoplasm and enhanced second‐strand synthesis. ss‐rAAV2‐miRNA133b vector specifically increased rAAV2 transduction in EGFR‐positive cells or tissues, while ss‐rAAV2‐Fluc‐miRNA133b exerted an antitumor effect. rAAV‐miRNA133b vector might emerge as a promising platform for delivering various transgene to treat EGFR‐positive cell‐related diseases, such as non‐small‐cell lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansGenetic VectorsErbB ReceptorsGenetic TherapyTransgenesDependovirusTransduction, Genetic

Stichwörter der Autor:innen

EGFR-protein tyrosine kinasemiRNA133brAAV2second-strand DNA synthesisubiquitination

Substanzen

ErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • College of Chemical Engineering and Materials Sciences, Quanzhou Normal University, Quanzhou, China.
  • School of Medicine, Huaqiao University, Quanzhou, China.

ORCID-Profile: Xiaoping Huang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huang, X., Wang, X., Li, L., Wang, Q., Xu, W., Wu, W., Xie, X., & Diao, Y. (2023). MiR133b ‐mediated inhibition of EGFR‐PTK pathway promotes rAAV2 transduction by facilitating intracellular trafficking and augmenting second‐strand synthesis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17858

Vancouver

Huang X, Wang X, Li L, Wang Q, Xu W, Wu W, et al. MiR133b ‐mediated inhibition of EGFR‐PTK pathway promotes rAAV2 transduction by facilitating intracellular trafficking and augmenting second‐strand synthesis. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17858

BibTeX
@article{Huang2023,
  author = {Huang, Xiaoping and Wang, Xiao and Li, Ling and Wang, Qizhao and Xu, Wentao and Wu, Wenlin and Xie, Xiaolan and Diao, Yong},
  title = {MiR133b ‐mediated inhibition of EGFR‐PTK pathway promotes rAAV2 transduction by facilitating intracellular trafficking and augmenting second‐strand synthesis},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  doi = {10.1111/jcmm.17858}
}
Kostenlos starten →